RMS is thought to originate from myogenic precursors expressing PAX3 [196], thus—due to its expression in most RMS tumors [197]—PAX3 has been tested in flow cytometry as a marker for circulating RMS cells, even if not for differential diagnosis since its expression has been described also in Ewing sarcoma [198]. Here, PAX3 is linked to Ewing sarcoma.